Table 3.
Duration of thiazide use | Patients (n) | Hip fractures | Person- years | Incidence rate* | Univariate model | Multivariate model† | ||
Crude HR (95% CI) | p Value | Adjusted HR (95% CI) | p Value | |||||
Non-user | 3735 | 92 | 6596.4 | 13.9 | 1 (ref) | 1 (ref) | ||
1–90 days | 1488 | 28 | 2710.1 | 10.3 | 0.76 (0.50 to 1.16) | 0.206 | 0.73 (0.48 to 1.13) | 0.160 |
91–365 days | 1296 | 22 | 2477.5 | 8.9 | 0.69 (0.43 to 1.09) | 0.111 | 0.69 (0.43 to 1.11) | 0.127 |
>365 days | 951 | 10 | 1887.3 | 5.3 | 0.42 (0.22 to 0.81) | 0.010 | 0.41 (0.22 to 0.79) | 0.008 |
*Per 1000 person-years.
†Multivariate Cox proportional hazard regression model, adjusting for all baseline characteristics (listed in table 1) and competing mortality.